“The British public are being urged to take part in trials to find out whether a third dose of Covid vaccine could protect against new variants.” [Source: bbc.com]
It is an open secret that the pharma industry and its stakeholders want annual vaccinations against COVID-19 to become the norm. Key figures such as Johnson & Johnson CEO Alex Gorsky, US National Institute of Allergy and Infectious Diseases Director Anthony Fauci and Pfizer CEO Albert Bourla have all recently made statements to this effect.
Notably, therefore, even before the announcement of the latest British trials, Nadhim Zahawi, the UK government’s vaccines minister, had already admitted on BBC television that his country’s National Health Service (NHS) is planning for annual COVID-19 vaccinations to take place.
As such, it is now clear that the pharma industry and its stakeholders view COVID-19 as a long-term business opportunity. As is also the case with other diseases, rather than seeking to bring the pandemic to an end, they see more profit potential in prolonging the crisis.
To read how COVID-19 vaccines are planned to be delivered via experimental skin patches, nasal sprays and pills in future, see this article on our website.